153 related articles for article (PubMed ID: 16563432)
1. The autocrine motility factor (AMF) and AMF-receptor combination needs sugar chain recognition ability and interaction using the C-terminal region of AMF.
Haga A; Tanaka N; Funasaka T; Hashimoto K; Nakamura KT; Watanabe H; Raz A; Nagase H
J Mol Biol; 2006 May; 358(3):741-53. PubMed ID: 16563432
[TBL] [Abstract][Full Text] [Related]
2. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.
Fairbank M; St-Pierre P; Nabi IR
Mol Biosyst; 2009 Aug; 5(8):793-801. PubMed ID: 19603112
[TBL] [Abstract][Full Text] [Related]
3. Inhibition mechanism of cytokine activity of human autocrine motility factor examined by crystal structure analyses and site-directed mutagenesis studies.
Tanaka N; Haga A; Uemura H; Akiyama H; Funasaka T; Nagase H; Raz A; Nakamura KT
J Mol Biol; 2002 May; 318(4):985-97. PubMed ID: 12054796
[TBL] [Abstract][Full Text] [Related]
4. Tumor autocrine motility factor induces hyperpermeability of endothelial and mesothelial cells leading to accumulation of ascites fluid.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2002 Apr; 293(1):192-200. PubMed ID: 12054583
[TBL] [Abstract][Full Text] [Related]
5. [Possibility that AMF will serve as a target molecule for the diagnosis and treatment of a metastatic neoplasm].
Haga A
Yakugaku Zasshi; 2005 Feb; 125(2):169-75. PubMed ID: 15684571
[TBL] [Abstract][Full Text] [Related]
6. Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.
Funasaka T; Haga A; Raz A; Nagase H
Int J Cancer; 2002 Sep; 101(3):217-23. PubMed ID: 12209971
[TBL] [Abstract][Full Text] [Related]
7. Autocrine motility factor/phosphoglucose isomerase regulates ER stress and cell death through control of ER calcium release.
Fu M; Li L; Albrecht T; Johnson JD; Kojic LD; Nabi IR
Cell Death Differ; 2011 Jun; 18(6):1057-70. PubMed ID: 21252914
[TBL] [Abstract][Full Text] [Related]
8. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
Jiang WG; Raz A; Douglas-Jones A; Mansel RE
J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
[TBL] [Abstract][Full Text] [Related]
9. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
10. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
11. Expression of autocrine motility factor/phosphohexose isomerase in Cos7 cells.
Lagana A; Duchaine T; Raz A; DesGroseillers L; Nabi IR
Biochem Biophys Res Commun; 2000 Jun; 273(1):213-8. PubMed ID: 10873589
[TBL] [Abstract][Full Text] [Related]
12. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
[TBL] [Abstract][Full Text] [Related]
13. Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K
Oncol Rep; 2002; 9(1):125-8. PubMed ID: 11748469
[TBL] [Abstract][Full Text] [Related]
14. Autocrine motility factor is a growth factor.
Silletti S; Raz A
Biochem Biophys Res Commun; 1993 Jul; 194(1):446-57. PubMed ID: 8392842
[TBL] [Abstract][Full Text] [Related]
15. The enzymatic activity of phosphoglucose isomerase is not required for its cytokine function.
Tsutsumi S; Gupta SK; Hogan V; Tanaka N; Nakamura KT; Nabi IR; Raz A
FEBS Lett; 2003 Jan; 534(1-3):49-53. PubMed ID: 12527360
[TBL] [Abstract][Full Text] [Related]
16. AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.
Haga A; Komazaki S; Funasaka T; Hashimoto K; Yokoyama Y; Watanabe H; Raz A; Nagase H
Leuk Lymphoma; 2006 Oct; 47(10):2234-43. PubMed ID: 17071500
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of mouse autocrine motility factor in complex with carbohydrate phosphate inhibitors provide insight into structure-activity relationship of the inhibitors.
Tanaka N; Haga A; Naba N; Shiraiwa K; Kusakabe Y; Hashimoto K; Funasaka T; Nagase H; Raz A; Nakamura KT
J Mol Biol; 2006 Feb; 356(2):312-24. PubMed ID: 16375918
[TBL] [Abstract][Full Text] [Related]
18. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jul; 285(1):118-28. PubMed ID: 11437381
[TBL] [Abstract][Full Text] [Related]
19. The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.
Kathagen-Buhmann A; Maire CL; Weller J; Schulte A; Matschke J; Holz M; Ligon KL; Glatzel M; Westphal M; Lamszus K
Neuro Oncol; 2018 Nov; 20(12):1594-1605. PubMed ID: 30053149
[TBL] [Abstract][Full Text] [Related]
20. Expression of autocrine motility-like factor in rheumatoid synovial fluid.
Watanabe H; Takeuchi K; Chigira M
J Rheumatol; 1994 Jan; 21(1):37-40. PubMed ID: 8151584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
